Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CCL11 Protein (AA 24-97) (His tag)

CCL11 Origin: Human Host: Escherichia coli (E. coli) Recombinant Greater than 95 % by SDS-PAGE gel analyses ELISA, WB
Catalog No. ABIN7281697
  • Target See all CCL11 products
    CCL11 (Chemokine (C-C Motif) Ligand 11 (CCL11))
    Protein Type
    Recombinant
    Protein Characteristics
    AA 24-97
    Origin
    • 5
    • 2
    • 1
    Human
    Source
    • 7
    • 1
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    This CCL11 protein is labelled with His tag.
    Application
    ELISA, Western Blotting (WB)
    Purity
    Greater than 95 % by SDS-PAGE gel analyses
    Sterility
    0.2 μm filtered
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    Buffer
    Lyophilized from a 0.2 μm filtered solution in PBS with 5 % trehalose, pH 7.4
    Storage
    4 °C,-20 °C
    Storage Comment
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    Expiry Date
    12 months
  • Target
    CCL11 (Chemokine (C-C Motif) Ligand 11 (CCL11))
    Alternative Name
    CCL11 (CCL11 Products)
    Synonyms
    SCYA11 Protein, Scya11 Protein, eotaxin Protein, Eotaxin Protein, C-C motif chemokine ligand 11 Protein, chemokine (C-C motif) ligand 11 Protein, CCL11 Protein, Ccl11 Protein
    Background
    C-C motif chemokine 11, CCL11, chemokine (C-C motif) ligand 11, Eosinophil chemotactic protein, Eotaxin, eotaxin-1, MGC22554, SCYA11Small-inducible cytokine A11, small inducible cytokine subfamily A (Cys-Cys), member 11 (eotaxin)
    Molecular Weight
    8.3 kDa
    UniProt
    P51671
    Pathways
    Regulation of Actin Filament Polymerization, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
You are here: